COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Jilin Zixin Pharmaceutical Co., Ltd. Announcement on the Dissolution of Shareholder Equity and Re-Pledge
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2013-040
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the dissolution of shareholder pledge and re-pledge
On October 11, 2013, the company received the controlling shareholder Dunhua Kangping Investment Co., Ltd. (hereinafter referred to as Kangping Company) Notice: Kangping Company pledges to Jilin Bank Co., Ltd. Changchun Ruixiang Sub-branch on October 15, 2012 (hereinafter referred to as : Jixing Ruixiang Branch) The company's unrestricted tradable shares of 26,000,000 shares (accounting for 5.07% of the company's total share capital) were processed on October 10, 2013 at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. On the same day, Kangping Company again pledged the above shares to Jixing Ruixiang Sub-branch, and handled the pledge registration formalities at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch. The pledge period began on October 10, 2013 until the pledgee handled the pledge. The date of registration.
Kangping Company holds a total of 251,475,016 shares of the company, of which 10,250,000 shares have been engaged in an agreed repurchase transaction. As of the date of this announcement, Kangping Company has plucked 240,430,000 shares of the Company (accounting for 95.61% of the shares held by Kangping Company), accounting for 46.87% of the company's total share capital.
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
October 12, 2013